81 related articles for article (PubMed ID: 9028625)
1. Multivariate discriminant analysis of biochemical parameters for the differentiation of clinically confounding liver diseases.
Salvatore F; Sacchetti L; Castaldo G
Clin Chim Acta; 1997 Jan; 257(1):41-58. PubMed ID: 9028625
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes.
Castaldo G; Oriani G; Lofrano MM; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1996 Aug; 42(8 Pt 1):1263-9. PubMed ID: 8697587
[TBL] [Abstract][Full Text] [Related]
3. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
[TBL] [Abstract][Full Text] [Related]
4. Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia.
Castaldo G; Oriani G; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1995 Mar; 41(3):439-43. PubMed ID: 7533673
[TBL] [Abstract][Full Text] [Related]
5. Serum lactate dehydrogenase isoenzyme 4/5 ratio discriminates between hepatocarcinoma and secondary liver neoplasia.
Castaldo G; Oriani G; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1991 Aug; 37(8):1419-23. PubMed ID: 1651182
[TBL] [Abstract][Full Text] [Related]
6. Ascitic pseudouridine discriminates between hepatocarcinoma-derived ascites and cirrhotic ascites.
Castaldo G; Intrieri M; Calcagno G; Cimino L; Budillon G; Sacchetti L; Salvatore F
Clin Chem; 1996 Nov; 42(11):1843-6. PubMed ID: 8906086
[TBL] [Abstract][Full Text] [Related]
7. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
Gasko R; Klímová N
Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of serum alkaline phosphatase and gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990).
Center SA; Slater MR; Manwarren T; Prymak K
J Am Vet Med Assoc; 1992 Oct; 201(8):1258-64. PubMed ID: 1358870
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing ascitic etiology on a biochemical basis.
Bansal S; Kaur K; Bansal AK
Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing between malignant and cirrhotic ascites by computerized step-wise discriminant functional analysis of its biochemistry.
Greene LS; Levine R; Gross MJ; Gordon S
Am J Gastroenterol; 1978 Nov; 70(5):448-54. PubMed ID: 742603
[TBL] [Abstract][Full Text] [Related]
11. Electrophoretic behavior and partial characterization of disease-associated serum forms of gamma-glutamyltransferase.
Sacchetti L; Castaldo G; Salvatore F
Electrophoresis; 1989; 10(8-9):619-27. PubMed ID: 2572416
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive diagnosis of liver cirrhosis: a comparison between four discriminant functions.
Corrao G; Carle F; Valenti M; Aricò S; Galatola G; Tabone M; Di Orio F
Rev Epidemiol Sante Publique; 1993; 41(2):123-30. PubMed ID: 8493390
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of fibronectin in the differential diagnosis of ascites.
Colli A; Buccino G; Cocciolo M; Parravicini R; Mariani F; Scaltrini G
Cancer; 1986 Dec; 58(11):2489-93. PubMed ID: 3021317
[TBL] [Abstract][Full Text] [Related]
14. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of cholinesterase determination in ascitic fluid in the differential diagnosis of ascites].
Vázquez Rodríguez de Alba J; Ena Muñoz J; Such Ronda J; Almenar Bonet MV; Graells Ferrer ML
An Med Interna; 2000 Jul; 17(7):351-5. PubMed ID: 10981331
[TBL] [Abstract][Full Text] [Related]
16. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
[TBL] [Abstract][Full Text] [Related]
17. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.
Boyer TD; Kahn AM; Reynolds TB
Arch Intern Med; 1978 Jul; 138(7):1103-5. PubMed ID: 666469
[TBL] [Abstract][Full Text] [Related]
19. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites.
Kountouras J; Boura P; Tsapas G; Charisis K; Magoula I; Tsakiri I
Anticancer Res; 1993; 13(6B):2441-5. PubMed ID: 8135481
[TBL] [Abstract][Full Text] [Related]
20. Discriminant analysis of biochemical parameters in liver disease.
Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
